Arkolith/Insider Trading/AKTS/Form 4

Vida Ventures II-A, LLC

10% OwnerAktis Oncology, Inc. (AKTS) · full profile →Form 4 · filed Jan 12, 2026
Net Buying
Open-Market Buys
$15.0M
Open-Market Sells
$0
Net Open-Market Flow
$15.0M
Transactions
8
4 non-derivative · 4 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 12, 2026Conversion(C)4.9M——4.9M
Jan 12, 2026Buy(P)23K$18.00$406K157K
Jan 12, 2026Conversion(C)135K——135K
Jan 12, 2026Buy(P)812K$18.00$14.6M5.7M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 12, 2026Conversion(C)14.8M—$00
Jan 12, 2026Conversion(C)412K—$00
Jan 12, 2026Conversion(C)101K—$00
Jan 12, 2026Conversion(C)3.6M—$00

Transaction Codes

C
Conversion of a derivative
P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-010617) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML